These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 677435)

  • 21. Furosemide facilitates recovery of evoked twitch response after pancuronium.
    Azar I; Cottrell J; Gupta B; Turndorf H
    Anesth Analg; 1980 Jan; 59(1):55-7. PubMed ID: 7188666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparative pharmacokinetics of the beta-1 receptor blookader celiprolol after a single oral administration in subjects with health kidneys and in patients with impaired renal function].
    Schmidt P; Takacs F; Pittner H; Minar E; Balcke P; Zazgornik J; Deutsch E
    Wien Klin Wochenschr; 1985 Sep; 97(18):729-32. PubMed ID: 2866633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Continuous skeletal muscle paralysis: effect on neonatal pulmonary mechanics.
    Bhutani VK; Abbasi S; Sivieri EM
    Pediatrics; 1988 Mar; 81(3):419-22. PubMed ID: 3344185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potentiation of atracurium by pancuronium during propofol-fentanyl-N2O anesthesia.
    Nathan N; Bonada G; Feiss P
    Acta Anaesthesiol Belg; 1996; 47(4):187-93. PubMed ID: 9093646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics and pharmacodynamics of 4-aminopyridine in anesthetized dogs.
    Rupp SM; Shinohara Y; Fisher DM; Miller RD; Castagnoli N
    J Pharmacol Exp Ther; 1983 May; 225(2):351-4. PubMed ID: 6842398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of pancuronium in patients with normal and impaired renal function.
    McLeod K; Watson MJ; Rawlins MD
    Br J Anaesth; 1976 Apr; 48(4):341-5. PubMed ID: 1276000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose-response and plasma concentration-response relationships of pancuronium in man.
    Shanks CA; Somogyi AA; Triggs EJ
    Anesthesiology; 1979 Aug; 51(2):111-8. PubMed ID: 453610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparative pharmacokinetics of pipecuronium bromide, pancuronium bromide and vecuronium bromide in anesthetized man].
    Yajima C; Sugai N; Hanaoka K; Numata K; Yamamoto K; Kushida Y; Murakami S; Yamamura H
    Masui; 1990 Jul; 39(7):882-9. PubMed ID: 1976829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pancuronium pharmacokinetics in patients with liver cirrhosis.
    Duvaldestin P; Agoston S; Henzel D; Kersten UW; Desmonts JM
    Br J Anaesth; 1978 Nov; 50(11):1131-6. PubMed ID: 718783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics, pharmacodynamics, and dose-response relationships of pancuronium in control and elderly subjects.
    Duvaldestin P; Saada J; Berger JL; D'Hollander A; Desmonts JM
    Anesthesiology; 1982 Jan; 56(1):36-40. PubMed ID: 7053668
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of ageing on the pharmacokinetics of pancuronium.
    McLeod K; Hull CJ; Watson MJ
    Br J Anaesth; 1979 May; 51(5):435-8. PubMed ID: 444344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of renal and hepatic function on pharmacodynamics and pharmacokinetics of non-depolarizing muscle relaxants.
    Booij LH
    Pharm Weekbl Sci; 1987 Apr; 9(2):56-60. PubMed ID: 2954027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kinetics of intercompartmental disposition and excretion of tubocurarine, gallamine, alcuronium and pancuronium in patients with normal and impaired renal function.
    Buzello W; Agoston S
    Anaesthesist; 1978 Jul; 27(7):319-21. PubMed ID: 150805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disposition and urinary excretion of vecuronium bromide in anesthetized patients with normal renal function or renal failure.
    Bencini AF; Scaf AH; Sohn YJ; Meistelman C; Lienhart A; Kersten UW; Schwarz S; Agoston S
    Anesth Analg; 1986 Mar; 65(3):245-51. PubMed ID: 2869722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Serum concentrations of pancuronium in anuric patients (author's transl)].
    Buzello W; Ruthven-Murray J
    Anaesthesist; 1976 Sep; 25(9):440-3. PubMed ID: 970599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of pancuronium in patients with normal and impaired renal function.
    Buzello W; Agoston S
    Anaesthesist; 1978 Jun; 27(6):291-7. PubMed ID: 677435
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative clinical pharmacokinetics of tubocurarine, gallamine, alcuronium and pancuronium.
    Buzello W; Agoston S
    Anaesthesist; 1978 Jul; 27(7):313-8. PubMed ID: 150804
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.